Biotechnology Risk Assessment Research in Maryland
Biotechnology Risk Assessment Research (10.219) awarded $3.0 million to recipients in Maryland in 6 grants from fiscal 2021 to 2025, 11% of the program's national total. University of Maryland, College Park received the most, $2.9 million.
- Awarded in Maryland$3.0 million
- Awards6
- Share of the program11%
- Rank among states1st of 24
- National total$26.9 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | No awards | |
| FY 2022 | 2 | $999,765 |
| FY 2023 | No awards | |
| FY 2024 | 3 | $1.3 million |
| FY 2025 | 1 | $649,999 |
Recipients in Maryland
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Maryland, College Park | Colleges and universities | 5 | $2.9 million |
| Society for in Vitro Biology, Incorporated | Nonprofits | 1 | $20,000 |
Open opportunities under this program
None is open or forecast on Grants.gov right now.
Questions people ask
How much Biotechnology Risk Assessment Research money goes to Maryland?
$3.0 million from fiscal 2021 to 2025, across 6 awards. Maryland ranks 1st of 24 states and territories for this program.
Who receives Biotechnology Risk Assessment Research money in Maryland?
The largest recipient is University of Maryland, College Park, with $2.9 million in 5 awards. Next is Society for in Vitro Biology, Incorporated.
Can organizations in Maryland apply now?
No opportunity under this program is open or forecast on Grants.gov right now. Programs often post once a year.
Biotechnology Risk Assessment Research in other states
Other large programs in Maryland
- Grants to States for Medicaid
- Greenhouse Gas Reduction Fund: National Clean Investment Fund
- Education Stabilization Fund
- Highway Planning and Construction
- USAID Foreign Assistance for Programs Overseas
- 1332 State Innovation Waivers
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies